Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients.
about
Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in KoreaRecent advances in multiple myeloma: a Korean perspectivePrognostic indicators of lenalidomide for multiple myeloma: consensus and controversy.Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients.Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting.A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma.
P2860
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lenalidomide with dexamethason ...... -experience from 110 patients.
@en
type
label
Lenalidomide with dexamethason ...... -experience from 110 patients.
@en
prefLabel
Lenalidomide with dexamethason ...... -experience from 110 patients.
@en
P2093
P2860
P1433
P1476
Lenalidomide with dexamethason ...... a-experience from 110 patients
@en
P2093
Chang-Ki Min
Cheolwon Suh
Deog-Yeon Jo
Hun-Mo Ryoo
Hyeon-Seok Eom
Hyun Jung Jun
Jae Hoon Lee
Jae-Yong Kwak
Je-Jung Lee
Jeong-Ok Lee
P2860
P304
P356
10.1007/S00277-013-1893-Z
P577
2013-09-12T00:00:00Z